Skip to main content
. 2016 Feb 24;7(11):11864–11880. doi: 10.18632/oncotarget.7689

Figure 6. SCCH decreases ERK1/2 pathway activation.

Figure 6

Western blot analysis was used to assess total A. and phosphorylated B. ERK1/2, which were corrected with β-actin expression level. SCCH does not affect total ERK1/2 expression A., but decreases ERK1/2 phosphorylation (i.e. activation) B.. Data are means ± SEM (n = 5-7 animals per group). * P < 0.05 compared with sham.